Literature DB >> 16120818

Podocyte hypertrophy, "adaptation," and "decompensation" associated with glomerular enlargement and glomerulosclerosis in the aging rat: prevention by calorie restriction.

Jocelyn E Wiggins1, Meera Goyal, Silja K Sanden, Bryan L Wharram, Kerby A Shedden, David E Misek, Rork D Kuick, Roger C Wiggins.   

Abstract

Whether podocyte depletion could cause the glomerulosclerosis of aging in Fischer 344 rats at ages 2, 6, 17, and 24 mo was evaluated. Ad libitum-fed rats developed proteinuria and glomerulosclerosis by 24 mo, whereas calorie-restricted rats did not. No evidence of age-associated progressive linear loss of podocytes from glomeruli was found. Rather, ad libitum-fed rats developed glomerular enlargement over time. To accommodate the increased glomerular volume, podocytes principally underwent hypertrophy, whereas other glomerular cells underwent hyperplasia. Stages of hypertrophy through which podocytes pass en route to podocyte loss and glomerulosclerosis were identified: Stage 1, normal podocyte; stage 2, nonstressed podocyte hypertrophy; stage 3, "adaptive" podocyte hypertrophy manifest by changes in synthesis of structural components (e.g., desmin) but maintenance of normal function; stage 4, "decompensated" podocyte hypertrophy relative to total glomerular volume manifest by reduced production of key machinery necessary for normal podocyte function (e.g., Wilms' tumor 1 protein [WT1], transcription factor pod1, nephrin, glomerular epithelial protein 1, podocalyxin, vascular endothelial growth factor, and alpha5 type IV collagen) and associated with widened foot processes and decreased filter efficiency (proteinuria); and stage 5, podocyte numbers decrease in association with focal segmental glomerulosclerosis. In contrast, in calorie-restricted rats, glomerular enlargement was minor, significant podocyte hypertrophy did not occur, podocyte machinery was unchanged, there was no proteinuria, and glomerulosclerosis did not develop. Glomerular enlargement therefore was associated with podocyte hypertrophy rather than hyperplasia. Hypertrophy above a certain threshold was associated with podocyte stress and then failure, culminating in reduced podocyte numbers in sclerotic glomeruli. This process could be prevented by calorie restriction.

Entities:  

Mesh:

Year:  2005        PMID: 16120818     DOI: 10.1681/ASN.2005050488

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  135 in total

1.  Global transcriptomic changes occur in aged mouse podocytes.

Authors:  Yuliang Wang; Diana G Eng; Natalya V Kaverina; Carol J Loretz; Abbal Koirala; Shreeram Akilesh; Jeffrey W Pippin; Stuart J Shankland
Journal:  Kidney Int       Date:  2020-06-25       Impact factor: 10.612

2.  Angiotensin II-dependent persistent podocyte loss from destabilized glomeruli causes progression of end stage kidney disease.

Authors:  Akihiro Fukuda; Larysa T Wickman; Madhusudan P Venkatareddy; Yuji Sato; Mahboob A Chowdhury; Su Q Wang; Kerby A Shedden; Robert C Dysko; Jocelyn E Wiggins; Roger C Wiggins
Journal:  Kidney Int       Date:  2011-09-21       Impact factor: 10.612

3.  De novo expression of podocyte proteins in parietal epithelial cells in experimental aging nephropathy.

Authors:  Jiong Zhang; Kim M Hansen; Jeffrey W Pippin; Alice M Chang; Yoshinori Taniguchi; Ronald D Krofft; Scott G Pickering; Zhi-Hong Liu; Christine K Abrass; Stuart J Shankland
Journal:  Am J Physiol Renal Physiol       Date:  2011-11-30

4.  Hepatocyte growth factor signaling ameliorates podocyte injury and proteinuria.

Authors:  Chunsun Dai; Moin A Saleem; Lawrence B Holzman; Peter Mathieson; Youhua Liu
Journal:  Kidney Int       Date:  2010-03-10       Impact factor: 10.612

Review 5.  Senile nephrosclerosis--does it explain the decline in glomerular filtration rate with aging?

Authors:  Andrew D Rule; Lynn D Cornell; Emilio D Poggio
Journal:  Nephron Physiol       Date:  2011-08-10

6.  Growth-dependent podocyte failure causes glomerulosclerosis.

Authors:  Akihiro Fukuda; Mahboob A Chowdhury; Madhusudan P Venkatareddy; Su Q Wang; Ryuzoh Nishizono; Tsukasa Suzuki; Larysa T Wickman; Jocelyn E Wiggins; Timothy Muchayi; Diane Fingar; Kerby A Shedden; Ken Inoki; Roger C Wiggins
Journal:  J Am Soc Nephrol       Date:  2012-07-05       Impact factor: 10.121

7.  FSGS as an Adaptive Response to Growth-Induced Podocyte Stress.

Authors:  Ryuzoh Nishizono; Masao Kikuchi; Su Q Wang; Mahboob Chowdhury; Viji Nair; John Hartman; Akihiro Fukuda; Larysa Wickman; Jeffrey B Hodgin; Markus Bitzer; Abhijit Naik; Jocelyn Wiggins; Matthias Kretzler; Roger C Wiggins
Journal:  J Am Soc Nephrol       Date:  2017-07-18       Impact factor: 10.121

Review 8.  Immune system modulation of kidney regeneration--mechanisms and implications.

Authors:  Hans-Joachim Anders
Journal:  Nat Rev Nephrol       Date:  2014-04-29       Impact factor: 28.314

Review 9.  Podocytes and glomerular function with aging.

Authors:  Jocelyn Wiggins
Journal:  Semin Nephrol       Date:  2009-11       Impact factor: 5.299

10.  Identifying advanced glycation end products as a major source of oxidants in aging: implications for the management and/or prevention of reduced renal function in elderly persons.

Authors:  Helen Vlassara; Jaime Uribarri; Luigi Ferrucci; Weijing Cai; Massimo Torreggiani; James B Post; Feng Zheng; Gary E Striker
Journal:  Semin Nephrol       Date:  2009-11       Impact factor: 5.299

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.